APA (7th ed.) Citation

Q, W., EA, M., Q, W., G, M., & Y, M. (2025). JCV-specific cell-based assays for PML risk assessment in lupus and multiple sclerosis patients with and without natalizumab. Frontiers in neurology, 16, 1584083. https://doi.org/10.3389/fneur.2025.1584083

Chicago Style (17th ed.) Citation

Q, Wu, Mills EA, Wang Q, Mao G, and Mao-Draayer Y. "JCV-specific Cell-based Assays for PML Risk Assessment in Lupus and Multiple Sclerosis Patients with and Without Natalizumab." Frontiers in Neurology 16 (2025): 1584083. https://doi.org/10.3389/fneur.2025.1584083.

MLA (9th ed.) Citation

Q, Wu, et al. "JCV-specific Cell-based Assays for PML Risk Assessment in Lupus and Multiple Sclerosis Patients with and Without Natalizumab." Frontiers in Neurology, vol. 16, 2025, p. 1584083, https://doi.org/10.3389/fneur.2025.1584083.